The Trial Lawyer Winter 2018 - Page 50

FDA MOVES TO MAKE Opioid Crisis SO MUCH WORSE By KJ McElrath The U.S. Food and Drug Administration has given its approval for a new, powerful and fast-acting opioid medication, despite serious concerns that it will only add to the current addiction crisis. The product, manufactured by a small San Francisco-area pharmaceutical company, was approved by an FDA committee by a 10–3 vote. The company, AcelRx Pharmaceuticals, specializes in pain therapies. It developed the new painkiller as an alternative to standard IV-administered analgesics for situations in which an IV is not practical, such as on-site emergencies, outpatient care, and battlefield first aid. According to company literature, Dsuvia (sufentanil) is: 48 x The Trial Lawyer